自身免疫性肝炎-原发性胆汁性胆管炎重叠综合征合并胃腺癌1例报告

李力晨; 汤绍辉

doi:10.3969/j.issn.1001-5256.2023.05.022

自身免疫性肝炎-原发性胆汁性胆管炎重叠综合征合并胃腺癌1例报告

DOI: 10.3969/j.issn.1001-5256.2023.05.022

李力晨,
汤绍辉^, ,

暨南大学附属第一医院消化内科，广州 510630

基金项目:

中央高校基本科研业务费专项资金 (21622315)

伦理学声明：本例报告已获得患者家属知情同意。

利益冲突声明：本文不存在任何利益冲突。

作者贡献声明：李力晨负责收集整理数据、资料分析、查阅文献、撰写论文；汤绍辉负责拟定写作思路，指导修改。

详细信息

通信作者:
汤绍辉, tangshaohui206@163.com (ORCID: 0000-0002-7217-1840)

计量
- 文章访问数: 357
- HTML全文浏览量: 134
- PDF下载量: 60
- 被引次数: 0
出版历程
- 收稿日期: 2022-09-01
- 出版日期: 2023-05-20

Autoimmune hepatitis-primary biliary cholangitis overlap syndrome with gastric adenocarcinoma: A case report

Lichen LI,
Shaohui TANG^{,
,}

Department of Gastroenterology, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China

Research funding:

The Fundamental Research Funds for the Central Universities (21622315)

More Information

Corresponding author: TANG Shaohui, tangshaohui206@163.com (ORCID: 0000-0002-7217-1840)

摘要

- 肝炎, 自身免疫性 /
- 原发性胆汁性胆管炎 /
- 胃肿瘤 /
- 诊断
- Hepatitis, Autoimmune /
- Primary Biliary Cholangitis /
- Stomach Neoplasms /
- Diagnosis

HTML全文

图 1 肝穿刺病理结果

注：a，汇管区淋巴细胞、浆细胞浸润，轻-中度界面炎(HE染色，×200)；b，肝细胞点状坏死，可见玫瑰花结样肝细胞(HE染色，×200)；c，汇管区桥接纤维化，局部假小叶形成(Masson染色，×40)；d，轻度细胆管增生(CK7染色，×40)。

Figure 1. Pathological results of hepatic puncture

下载: 全尺寸图片幻灯片

图 2 胃镜检查图像

注：a，胃角后壁见一隆起型病变，表面可见多个溃疡面，覆白苔；b，食管下段四壁各见一条曲张静脉。

Figure 2. Images of gastroscopy

下载: 全尺寸图片幻灯片

参考文献(18)

[1]	BEUERS U, GERSHWIN ME, GISH RG, et al. Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'[J]. J Hepatol, 2015, 63(5): 1285-1287. DOI: 10.1016/j.jhep.2015.06.031.
[2]	DUAN WJ, LYU TT, CHEN S, et al. Clinical features and prognosis of autoimmune hepatitis with antimitochondrial antibody posistive[J]. J Clin Exp Med, 2022, 21(18): 1931-1934. DOI: 10.3969/j.issn.1671-4695.2022.18.008. 段维佳, 吕婷婷, 陈莎, 等. 抗线粒体抗体自身免疫性肝炎患者的临床特点及预后[J]. 临床和实验医学杂志, 2022, 21(18): 1931-1934. DOI: 10.3969/j.issn.1671-4695.2022.18.008.
[3]	TO U, SILVEIRA M. Overlap syndrome of autoimmune hepatitis and primary biliary cholangitis[J]. Clin Liver Dis, 2018, 22(3): 603-611. DOI: 10.1016/j.cld.2018.03.010.
[4]	JIANG Y, XU BH, RODGERS B, et al. Characteristics and inpatient outcomes of primary biliary cholangitis and autoimmune hepatitis overlap syndrome[J]. J Clin Transl Hepatol, 2021, 9(3): 392-398. DOI: 10.14218/JCTH.2021.00008.
[5]	CHAZOUILLÈRES O, WENDUM D, SERFATY L, et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy[J]. Hepatology, 1998, 28(2): 296-301. DOI: 10.1002/hep.510280203.
[6]	European Association for the Study of the Liver. EASL clinical practice guidelines: management of cholestatic liver diseases[J]. J Hepatol, 2009, 51(2): 237-267. DOI: 10.1016/j.jhep.2009.04.009.
[7]	WANG Q, SELMI C, ZHOU X, et al. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis[J]. J Autoimmun, 2013, 41: 140-145. DOI: 10.1016/j.jaut.2012.10.004.
[8]	ZHANG JF, XU HM, SONG HY, et al. Autoimmune hepatitis-primary biliary cholangitis overlap syndrome: poor diagnostic sensitivity of Paris' criteria in Chinese patients[J]. J Prac Hepatol, 2019, 22(4): 537-540. DOI: 10.3969/j.issn.1672-5069.2019.04.022. 张骏飞, 许何明, 宋海燕, 等. 自身免疫性肝炎-原发性胆汁性胆管炎重叠综合征: 巴黎标准诊断中国患者灵敏度低[J]. 实用肝脏病杂志, 2019, 22(4): 537-540. DOI: 10.3969/j.issn.1672-5069.2019.04.022.
[9]	Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the diagnosis and management of primary biliary cholangitis (2021)[J]. J Clin Hepatol, 2022, 38(1): 35-41. DOI: 10.3760/cma.j.cn112138-20211112-00794 中华医学会肝病学分会. 原发性胆汁性胆管炎的诊断和治疗指南(2021)[J]. 临床肝胆病杂志, 2022, 38(1): 35-41. DOI: 10.3760/cma.j.cn112138-20211112-00794
[10]	HEURGUÉ A, VITRY F, DIEBOLD MD, et al. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease[J]. Gastroenterol Clin Biol, 2007, 31(1): 17-25. DOI: 10.1016/s0399-8320(07)89323-7.
[11]	FAN X, ZHU Y, MEN R, et al. Efficacy and safety of immunosuppressive therapy for PBC-AIH overlap syndrome accompanied by decompensated cirrhosis: A real-world study[J]. Can J Gastroenterol Hepatol, 2018, 2018: 1965492. DOI: 10.1155/2018/1965492.
[12]	CHAZOUILLÈRES O, WENDUM D, SERFATY L, et al. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome[J]. J Hepatol, 2006, 44(2): 400-406. DOI: 10.1016/j.jhep.2005.10.017.
[13]	ANNIBALE B, ESPOSITO G, LAHNER E. A current clinical overview of atrophic gastritis[J]. Expert Rev Gastroenterol Hepatol, 2020, 14(2): 93-102. DOI: 10.1080/17474124.2020.1718491.
[14]	LANDGREN AM, LANDGREN O, GRIDLEY G, et al. Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans[J]. Cancer, 2011, 117(6): 1163-1171. DOI: 10.1002/cncr.25524.
[15]	JENSEN MD, JEPSEN P, VILSTRUP H, et al. Increased cancer risk in autoimmune hepatitis: A Danish Nationwide Cohort Study[J]. Am J Gastroenterol, 2022, 117(1): 129-137. DOI: 10.14309/ajg.0000000000001525.
[16]	SHARMA R, VERNA EC, SIMON TG, et al. Cancer risk in patients with autoimmune hepatitis: A nationwide population-based cohort study with histopathology[J]. Am J Epidemiol, 2022, 191(2): 298-319. DOI: 10.1093/aje/kwab119.
[17]	LI XC, SUN SF, WANG Y. A case of autoimmune hepatitis with early gastric cancer[J]. Chin J Difficult Comp Cases, 2002, 1(3): 174-174. DOI: 10.3969/j.issn.1671-6450.2002.03.035. 李希臣, 孙松峰, 汪毅. 自身免疫性肝炎合并早期胃癌1例[J]. 疑难病杂志, 2002, 1(3): 174-174. DOI: 10.3969/j.issn.1671-6450.2002.03.035.
[18]	YANG MM, ZHOU L, LIN R, et al. Clinical characteristics and the incidence of extrahepatic autoimmune disease and malignant tumor in primary biliary cirrhosis-autoimmune hepatitis overlap syndrome[J]. Chin J Dig, 2013, 33(9): 596-600. DOI: 10.3760/cma.j.issn.0254-1432.2013.09.004. 杨蜜蜜, 周璐, 林睿, 等. 原发性胆汁性肝硬化-自身免疫性肝炎重叠综合征的临床病理特征及肝外自身免疫性疾病和恶性肿瘤的发生情况[J]. 中华消化杂志, 2013, 33(9): 596-600. DOI: 10.3760/cma.j.issn.0254-1432.2013.09.004.